Pulmonary Specialist-Health Coach Consult Model Pilot
追踪信息 | |||
---|---|---|---|
首次提交日期 ICMJE | October 2, 2018 | ||
首次发布日期e ICMJE | October 4, 2018 | ||
最后更新发布日期 | October 4, 2018 | ||
预计研究开始日期 ICMJE | February 1, 2019 | ||
预计主要完成日期 | June 30, 2019 (主要结果测量的最终数据收集日期) | ||
目前主要观察指标 ICMJE |
Receipt of recommended care[ Time Frame: 3 months after referral ] Number of specialist recommendations implemented by the patient; Denominator: Number of recommendations made by specialist |
||
原始主要观察测量 ICMJE | 与当前相同 | ||
目前的二级观察 ICMJE |
|
||
描述性信息 | |||
简略标题 ICMJE | Pulmonary Specialist-Health Coach Consult Model Pilot | ||
正式标题 ICMJE | Pulmonary Specialist-Health Coach Consult (PuSHCon) Model to Improve Access to Specialist Consultation and Receipt of Recommended Evidence-based Care for Vulnerable Patients With Chronic Obstructive Pulmonary Disease (COPD) and Asthma | ||
简要概况 | The Pulmonary Specialist-Health Coach Consultation (PuSHCon) study examines the implemention of health coach-assisted consultations to improve access to specialist care and implementation of specialist recommendations for patients with COPD, asthma, and asthma COPD overlap syndrome (ACOS) for low-income and vulnerable patients seen at public health clinics. A limited number of patients (50) from two clinics will be enrolled in the pilot study; 25 patients from one clinic will receive a pulmonary consultation under usual care and 25 patients from the other clinic will receive the PuSHCon model. |
||
详细说明 | While evidence-based care for chronic obstructive pulmonary disease (COPD) and asthma can substantially reduce disease burden and prevent emergency visits and hospitalizations, it is estimated that 55% of patients with COPD do not receive all recommended care and that less than 50% of patients with asthma are well controlled. The proposed study is a one-year cluster randomized controlled pilot trial comparing the Pulmonary specialist-health coach (PuSHCon) model to usual care for primary care patients referred for a consultation with a pulmonary specialist. This study is intended to prepare the way for a larger randomized controlled trial comparing the PuSHCon model to usual care for primary care patients referred for a consultation with a pulmonary specialist. The investigators will use a combination of quantitative and qualitative methods to assess the implementation the PuSHCon model and measurement of patient-centered outcomes (Specific Aim 1) and the impact of PuSHCon model on patient reported quality of care, satisfaction, and patient receipt of care recommended by the pulmonary specialist (Specific Aim 2). The results of the current study will provide initial enrollment for a subsequent 5 year randomized controlled trial. | ||
研究类型 ICMJE | Interventional | ||
研究阶段 | N/A | ||
研究设计 ICMJE | 分配: Randomized 干预模型: Parallel Assignment 干预模型描述: Cluster randomized controlled trial 盲法: Interventional 盲法描述:Investigators and the Data Safety Monitoring Board will receive data summaries that mask identification of groups. 主要目的: Health Services Research |
||
适用条件 ICMJE | |||
干预项目 ICMJE |
|
||
研究工具 |
|
||
招募信息 | |||
招募状态 ICMJE | Not yet recruiting | ||
预计入组 ICMJE |
50 | ||
原始预计入组 ICMJE | 与当前相同 | ||
预计研究完成日期 | August 30, 2019 | ||
预计主要完成日期 | June 30, 2019 (主要结果测量的最终数据收集日期) | ||
合格标准 ICMJE | Inclusion Criteria: - English or Spanish speaking - At last 18 years of age - Diagnosed with asthma or COPD - Referred to see a pulmonary specialist Exclusion Criteria: - Do not plan to attend primary care clinic for at least 3 months - Cognitive dysfunction that would prevent interaction with a health coach - Not having a phone at which the participant can be reached | ||
性别 |
|
||
年龄 | 最小年龄:18 Years ,最大年龄:N/A | ||
接受健康的志愿者 | 没有 | ||
可入组国家 ICMJE | United States | ||
管理信息 | 数据检测委员会 | Yes | |
研究涉及美国FDA监管的产品 |
研究美国FDA监管的药品: No 研究涉及美国FDA监管的设备产品: No |
||
IPD 共享声明 |
|
||
责任方 | , | ||
研究赞助商 ICMJE | University of California, San Francisco | ||
合作者 ICMJE | |||
研究员 ICMJE |
|
||
PRS 账户 | |||
验证日期 | October 2018 | ||
ICMJE 国际医学期刊编辑委员会和 世界卫生组织 ICTRP 要求的元素 |